SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-028562
Filing Date
2020-06-08
Accepted
2020-06-08 09:18:56
Documents
14
Period of Report
2020-06-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srpt-8k_20200604.htm   iXBRL 8-K 89341
2 EX-3.1 srpt-ex31_24.htm EX-3.1 8190
3 EX-10.1 srpt-ex101_25.htm EX-10.1 6797
  Complete submission text file 0001564590-20-028562.txt   246376

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA srpt-20200604.xsd EX-101.SCH 5820
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20200604_lab.xml EX-101.LAB 20244
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20200604_pre.xml EX-101.PRE 12117
12 EXTRACTED XBRL INSTANCE DOCUMENT srpt-8k_20200604_htm.xml XML 3689
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 20948247
SIC: 2834 Pharmaceutical Preparations